ARTICLE | Clinical News
Veliparib: Ph III data
April 21, 2017 8:31 PM UTC
Top-line data from a double-blind, international Phase III trial in 312 patients with early stage TNBC showed that oral veliparib plus carboplatin and paclitaxel missed the primary endpoint of improvi...
BCIQ Company Profiles
BCIQ Target Profiles